Recently, according to Brazilian media outlet Gaz, Brazil's National Health Surveillance Agency (Anvisa) has initiated a public consultation regarding the use of e-cigarettes in Brazil. The consultation, which will last until February 9th, allows the public to provide their opinions and suggestions through an online form. After the consultation period, Anvisa will evaluate the received feedback and release a final report.
According to an announcement by Brazil's National Health Surveillance Agency (Anvisa), they are considering reevaluating the regulations that have been in place since 2009, which prohibit the use of electronic smoking devices nationwide. This potential change would affect all types of e-cigarettes. The proposal also contemplates banning advertisements of these products in any media, whether electronic or non-electronic, as well as any other form of public consumer promotion.
Electronic smoking devices (ESDs) have a diverse range of technologies and have been continuously improved over time. Currently, there are various types available on the market, including e-cigarettes and box mod e-cigarettes, some of which are even equipped with rechargeable batteries or interchangeable e-liquids. According to the Brazilian National Health Surveillance Agency (Anvisa), a ban implemented in Brazil in 2009 covers all types of electronic smoking devices, including their sales, imports, and advertising.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
